Table 4: Diabetes biometrics reported in health facility records of enrolled Syrian and Lebanese patients with type 2 diabetes and hypertension.
|
Overalla |
By Region |
P-value for regional comparisonb
|
By Population |
P-value for population comparisonb
|
| (n=870) |
South (n=260) |
Bekaa (n=279) |
GB/ML (n=331) |
Syrian(n=637) |
Lebanese (n=330) |
| Point |
95% CI |
Point |
95% CI |
Point |
95% CI |
Point |
95% CI |
Point |
95% CI |
Point |
95% CI |
| Diabetes |
n=460 |
n=137 |
n=142 |
n=181 |
|
n=198 |
n=136 |
–
|
| % of diabetes patients with blood test resultsc
|
37.6% |
(33.2-42.2%) |
21.9% |
(15.3-29.8%) |
21.8% |
(15.3-29.5%) |
61.9% |
(54.4-69.0%) |
< 0.001 |
37.3% |
(30.6-44.4%) |
48.6% |
(40.0-57.2%) |
0.039 |
|
n=170 |
n=30 |
n=31 |
n=109 |
– |
n=73 |
n=66 |
– |
| Controlled |
43.5% |
(36.0-51.3%) |
43.3% |
(25.5-62.6%) |
12.9% |
(3.6-29.8%) |
52.3% |
(42.5-61.9%) |
< 0.001 |
45.2% |
(33.5-57.3%) |
53.0% |
(40.3-65.4%) |
0.357 |
| Uncontrolled |
56.5% |
(48.7-64.0%) |
56.7% |
(37.4-74.5%) |
87.1% |
(70.2-96.4%) |
47.7% |
(38.1-57.5%) |
54.8% |
(42.7-66.5%) |
47.0% |
(34.6-59.7%) |
| HbA1C |
n=460 |
n=137 |
n=142 |
n=181 |
– |
n=198 |
n=136 |
– |
| % of diabetes patients with HbA1C test |
33.3% |
(29.0-37.8%) |
21.9% |
(15.3-29.8%) |
14.8% |
(9.4-21.7%) |
56.4% |
(48.8-63.7%) |
< 0.001 |
34.3% |
(27.8-41.4%) |
47.1% |
(38.4-55.8%) |
0.057 |
|
n=153 |
n=30 |
n=21 |
n=102 |
– |
n=68 |
n=64 |
– |
| Mean |
7.3 |
(7.1-7.5) |
7.5 |
(6.9-8.1) |
8.2 |
(7.6-8.8) |
7.0 |
(6.8-7.2) |
< 0.001 |
7.3 |
(6.9-7.6) |
7.0 |
(6.7-7.4) |
0.284 |
| HbA1C<7.0% |
48.4% |
(40.2-56.6%) |
43.3% |
(25.5-62.6%) |
19.0% |
(5.4-41.9%) |
55.9% |
(45.7-65.7%) |
< 0.001 |
48.5% |
(36.2-61.0%) |
54.7% |
(41.7-67.2%) |
0.709 |
| HbA1C = 7.0-7.9% |
21.6% |
(15.3-28.9%) |
16.7% |
(5.6-34.7%) |
14.3% |
(3.0-36.3%) |
24.5% |
(16.5-34.0%) |
22.1% |
(12.9-33.8%) |
21.9% |
(12.5-34.0%) |
| HbA1C > 8.0% |
30.1% |
(22.9-38.0%) |
40.0% |
(22.7-59.4%) |
66.7% |
(43.0-85.4%) |
19.6% |
(12.4-28.6%) |
29.4% |
(19.0-41.7%) |
23.4% |
(13.8-35.7%) |
| Blood Sugar |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
| Random Blood Sugar (Blood Glucose) |
n=460 |
n=137 |
n=142 |
n=181 |
– |
n=198 |
n=136 |
– |
| % of diabetes patients with random blood sugar test |
9.1% |
(6.7-12.1%) |
0% |
(0.0-2.7%) |
0% |
(0.0-2.6%) |
23.2% |
(17.3-30.0%) |
< 0.001 |
7.1% |
(3.9-11.6%) |
19.9% |
(13.5-27.6%) |
0.001 |
|
n=42 |
n=0 |
n=0 |
n=42 |
– |
n=14 |
n=27 |
– |
| Mean |
158 |
(145-171) |
– |
– |
– |
– |
158 |
(145-171) |
– |
163 |
(137-189) |
158 |
(143-173) |
0.712 |
| Random Blood Sugar < 120mg/dL |
14.3% |
(5.4-28.5%) |
– |
– |
– |
– |
14.3% |
(5.4-28.5%) |
– |
7.1% |
(0.2-33.9%) |
14.8% |
(4.2-33.7%) |
0.477 |
| Random Blood Sugar > 120mg/dL |
85.7% |
(71.5-94.6%) |
– |
– |
– |
– |
85.7% |
(71.5-94.6%) |
92.9% |
(66.1-99.8%) |
85.2% |
(66.3-95.8%) |
| Fasting Blood Sugar (Blood Glucose) |
n=460 |
n=137 |
n=142 |
n=181 |
– |
n=198 |
n=136 |
– |
| % of diabetes patients with fasting blood sugar test |
24.8% |
(20.9-29.0%) |
0.7% |
(0.0-4.0%) |
16.9% |
(11.1-24.1%) |
49.2% |
(41.7-56.7%) |
< 0.001 |
19.7% |
(14.4-25.9%) |
36.8% |
(28.7-45.5%) |
0.003 |
|
n=114 |
n=1 |
n=24 |
n=89 |
– |
n=39 |
n=50 |
– |
| Mean |
146 |
(138-154) |
90 |
– |
174 |
(155-194) |
139 |
(131-147) |
0.001 |
145 |
(132-158) |
137 |
(126-149) |
0.385 |
| Fasting Blood Sugar < 100mg/dL |
12.3% |
(6.9-19.7%) |
100% |
(2.5-100.0%) |
4.2% |
(0.1-21.1%) |
13.5% |
(7.2-22.4%) |
0.013 |
10.3% |
(2.9-24.2%) |
16.0% |
(7.2-29.1%) |
0.431 |
| Fasting Blood Sugar > 100mg/dL |
87.7% |
(80.3-93.1%) |
0% |
(0.0-97.5%) |
95.8% |
(78.9-99.9%) |
86.5% |
(77.6-92.8%) |
89.7% |
(75.8-97.1%) |
84.0% |
(70.9-92.8%) |
GB/ML = Greater Beirut/Mount Lebanon; 95% CI = 95% confidence interval; a Includes Syrian refugee and Lebanese host community patients as well as enrolled patients with other nationalities; b Independent t-test for continuous variables, Chi-square test for categorical variables; c Includes HbA1C, fasting blood sugar, random blood sugar, or any combination of those tests.